The FDA's (https://www.marketwatch.com/story/fda-advisers-vote-against-sleep-peptide-as-they-debate-safety-and-health-claims-2bc85739?mod=mw_rss_topstories) today killed a wellness narrative that was already cannibalizing discretionary health spending at the margins — but here's what matters: retail pharmacy and supplement aisles were banking on premium markup premiums on unregulated health claims, and that moat just evaporated.

Research these companies